Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nerdy A | NRDY | Oct 11, 2024 | 0.99 | +1.26 |
Net Lease Office Properties When Issued | NLOP | Oct 11, 2024 | 31.02 | +2.61 |
Net Power A | NPWR | Oct 11, 2024 | 6.90 | +0.73 |
NetApp | NTAP | Oct 11, 2024 | 126.93 | +1.56 |
Netcapital | NCPL | Oct 11, 2024 | 1.60 | +3.90 |
NetEase ADR | NTES | Oct 11, 2024 | 88.35 | +0.30 |
Netflix | NFLX | Oct 11, 2024 | 722.79 | -1.03 |
NETGEAR | NTGR | Oct 11, 2024 | 20.85 | +4.93 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Oct 11, 2024 | 50.06 | +0.50 |
NetScout Systems | NTCT | Oct 11, 2024 | 21.71 | +3.18 |
NETSOL Technologies | NTWK | Oct 11, 2024 | 3.20 | +2.40 |
Netstreit | NTST | Oct 11, 2024 | 15.70 | +1.68 |
Network-1 Technologies | NTIP | Oct 11, 2024 | 1.34 | -0.74 |
Neuberger Berman | NML | Oct 11, 2024 | 8.46 | +0.24 |
Neuberger Berman High Yield Strategies Fund | NHS | Oct 11, 2024 | 8.33 | -1.30 |
Neuberger Berman Municipal Fund | NBH | Oct 11, 2024 | 11.11 | +0.36 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Oct 11, 2024 | 13.05 | +0.23 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Oct 11, 2024 | 3.97 | +0.76 |
NeueHealth | NEUE | Oct 11, 2024 | 5.85 | +4.45 |
Neumora Therapeutics | NMRA | Oct 11, 2024 | 15.51 | +0.71 |
Neuraxis | NRXS | Oct 11, 2024 | 2.80 | -2.79 |
Neurobo Pharmaceuticals | NRBO | Oct 11, 2024 | 2.56 | +3.64 |
Neurocrine Biosciences | NBIX | Oct 11, 2024 | 115.49 | +2.74 |
Neurogene | NGNE | Oct 11, 2024 | 49.43 | +2.66 |
NeuroMetrix | NURO | Oct 11, 2024 | 4.06 | -2.09 |
Neuronetics | STIM | Oct 11, 2024 | 0.91 | +5.81 |
NeuroOne | NMTC | Oct 11, 2024 | 0.92 | +1.10 |
Neuropace | NPCE | Oct 11, 2024 | 6.61 | +6.44 |
NeuroSense Therapeutics | NRSN | Oct 11, 2024 | 1.13 | -7.38 |
Nevro | NVRO | Oct 11, 2024 | 4.83 | +4.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.